» Articles » PMID: 26887977

GRHL2-miR-200-ZEB1 Maintains the Epithelial Status of Ovarian Cancer Through Transcriptional Regulation and Histone Modification

Overview
Journal Sci Rep
Specialty Science
Date 2016 Feb 19
PMID 26887977
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-mesenchymal transition (EMT), a biological process by which polarized epithelial cells convert into a mesenchymal phenotype, has been implicated to contribute to the molecular heterogeneity of epithelial ovarian cancer (EOC). Here we report that a transcription factor--Grainyhead-like 2 (GRHL2) maintains the epithelial phenotype. EOC tumours with lower GRHL2 levels are associated with the Mes/Mesenchymal molecular subtype and a poorer overall survival. shRNA-mediated knockdown of GRHL2 in EOC cells with an epithelial phenotype results in EMT changes, with increased cell migration, invasion and motility. By ChIP-sequencing and gene expression microarray, microRNA-200b/a is identified as the direct transcriptional target of GRHL2 and regulates the epithelial status of EOC through ZEB1 and E-cadherin. Our study demonstrates that loss of GRHL2 increases the levels of histone mark H3K27me3 on promoters and GRHL2-binding sites at miR-200b/a and E-cadherin genes. These findings support GRHL2 as a pivotal gatekeeper of EMT in EOC via miR-200-ZEB1.

Citing Articles

GRHL2 regulates keratinocyte EMT-MET dynamics and scar formation during cutaneous wound healing.

Chen T, Zhang B, Xie H, Huang C, Wu Q Cell Death Dis. 2024; 15(10):748.

PMID: 39402063 PMC: 11473813. DOI: 10.1038/s41419-024-07121-7.


GRHL2 suppression of NT5E/CD73 in breast cancer cells modulates CD73-mediated adenosine production and T cell recruitment.

Coban B, Wang Z, Liao C, Beslmuller K, Timmermans M, Martens J iScience. 2024; 27(5):109738.

PMID: 38706844 PMC: 11068632. DOI: 10.1016/j.isci.2024.109738.


Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence.

MacFawn I, Farris J, Pifer P, Margaryan N, Akhter H, Wang L Mol Immunol. 2024; 170:156-169.

PMID: 38692097 PMC: 11106721. DOI: 10.1016/j.molimm.2024.04.012.


Exploration of the Correlation Between Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy.

Guo S, Bai W, Cui F, Chen X, Fang X, Shen H Pharmgenomics Pers Med. 2024; 17:91-103.

PMID: 38586176 PMC: 10999208. DOI: 10.2147/PGPM.S453061.


Multi-omics integration reveals a nonlinear signature that precedes progression of lung fibrosis.

Pattaroni C, Begka C, Cardwell B, Jaffar J, Macowan M, Harris N Clin Transl Immunology. 2024; 13(1):e1485.

PMID: 38269243 PMC: 10807351. DOI: 10.1002/cti2.1485.


References
1.
Kurrey N, K A, Bapat S . Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol. 2005; 97(1):155-65. DOI: 10.1016/j.ygyno.2004.12.043. View

2.
Tan T, Miow Q, Miki Y, Noda T, Mori S, Huang R . Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014; 6(10):1279-93. PMC: 4287932. DOI: 10.15252/emmm.201404208. View

3.
Wilanowski T, Caddy J, Ting S, Hislop N, Cerruti L, Auden A . Perturbed desmosomal cadherin expression in grainy head-like 1-null mice. EMBO J. 2008; 27(6):886-97. PMC: 2274933. DOI: 10.1038/emboj.2008.24. View

4.
Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

5.
Kokoszynska K, Ostrowski J, Rychlewski L, Wyrwicz L . The fold recognition of CP2 transcription factors gives new insights into the function and evolution of tumor suppressor protein p53. Cell Cycle. 2008; 7(18):2907-15. DOI: 10.4161/cc.7.18.6680. View